RADIATION ONCOLOGY

AIM Clinical Guidelines for Radiation Oncology

Radiation Therapy

The AIM Clinical Appropriateness Guidelines for Radiation Therapy address brachytherapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery.

For commercial and Medicare members

OPEN THE GUIDELINES FOR RADIATION THERAPY EFFECTIVE NOVEMBER 6, 2022

For Medicaid members

OPEN THE GUIDELINES FOR RADIATION THERAPY EFFECTIVE MARCH 13, 2022

For commercial, Medicare, and Medicaid members

COMING SOON RADIATION THERAPY GUIDELINES EFFECTIVE APRIL 9, 2023

 

Proton Beam Therapy

The AIM Clinical Appropriateness Guidelines for Proton Beam Therapy address proton beam therapy, also known as proton radiation therapy or proton radiotherapy.

OPEN THE GUIDELINES FOR PROTON BEAM THERAPY EFFECTIVE MARCH 13, 2022 

 

Perirectal Hydrogel Spacer for Prostate Radiotherapy

The AIM Clinical Appropriateness Guidelines for Perirectal Hydrogel Spacer for Prostate Radiotherapy address the use of an implanted hydrogel spacer when radiation therapy is used to treat prostate cancer.

OPEN THE GUIDELINES FOR PERIRECTAL HYDROGEL SPACER EFFECTIVE NOVEMBER 6, 2022

Medical policy SURG.00143 Perirectal Spacers for Use During Prostate Radiotherapy was archived effective November 6, 2022

 

Code cross-reference guide

Download a helpful spreadsheet to find current and archived procedure codes for each solution!

Anthem medical policy site:

For a complete listing of medical policies, please go to Anthem Provider site > select your state > Scroll down page, select Review Policies > view Medical Policies & Clinical UM Guidelines

Other client policy sites:

Other Clinical Guidelines

Archived Guidelines

For guidelines older than 3 years, please contact AIM.guidelines@aimspecialtyhealth.com

Radiation Therapy (excludes Proton)
Proton Beam Therapy